A Different Approach to Treating Depression
Traditional antidepressants like SSRIs (Prozac, Zoloft, Lexapro) work by increasing serotonin levels in the brain. While effective for many people, they take 4-8 weeks to produce noticeable improvements and fail to help roughly one-third of depression patients entirely.
Ketamine operates through a fundamentally different mechanism. Instead of targeting serotonin, it acts on the glutamate system -- the brain's primary excitatory neurotransmitter network. This distinction explains both its rapid onset and its effectiveness in patients who have not responded to conventional treatments.
The Mechanism: Step by Step
NMDA Receptor Blockade
Ketamine is an NMDA receptor antagonist. It temporarily blocks N-methyl-D-aspartate (NMDA) receptors on certain inhibitory interneurons in the brain. These interneurons normally act as brakes on neural activity. By blocking them, ketamine briefly releases that brake.
Glutamate Surge
With the inhibitory interneurons temporarily quieted, there is a burst of glutamate release in the prefrontal cortex and other brain regions involved in mood regulation. This glutamate surge activates AMPA receptors on downstream neurons, triggering a cascade of molecular signaling events.
BDNF Release and mTOR Activation
The glutamate cascade stimulates the release of brain-derived neurotrophic factor (BDNF), a protein essential for neuron health and growth. BDNF in turn activates the mTOR signaling pathway, which is a master regulator of protein synthesis and cellular growth in the brain.
Synaptogenesis -- New Neural Connections
The mTOR pathway triggers rapid formation of new synapses -- the connections between neurons. Research has shown that ketamine can increase the number of dendritic spines (the physical structures of synapses) within hours. In depressed patients, many of these connections have been lost or weakened; ketamine helps restore them.
A 2010 study by Li et al. published in Science demonstrated that a single dose of ketamine rapidly increased synapse number and function in the prefrontal cortex of rats, reversing the synaptic deficits caused by chronic stress. These structural changes correlated directly with antidepressant behavioral effects.
Why Ketamine Works So Fast
The speed of ketamine's antidepressant effect is directly tied to its mechanism:
- SSRIs gradually increase serotonin availability, which then slowly triggers downstream neuroplastic changes over weeks. The delay comes from the indirect, multi-step nature of the process.
- Ketamine directly triggers the molecular machinery of synaptogenesis within hours. New synaptic connections begin forming almost immediately after the glutamate surge, which is why patients can feel improvement within hours to days rather than weeks.
This is not just about blocking a receptor -- it is about triggering the brain's own repair and growth mechanisms in an accelerated timeframe.
Forms of Ketamine Treatment
Ketamine is available in several forms, each with different characteristics:
| Form | Route | Setting | Bioavailability |
|---|---|---|---|
| IV Infusion | Intravenous | Clinic only | ~100% |
| IM Injection | Intramuscular | Clinic only | ~93% |
| Esketamine (Spravato) | Intranasal | Certified clinic | ~48% |
| Sublingual (lozenges/troches) | Under tongue | At home | ~30% |
| Oral tablets | Swallowed | At home | ~17-24% |
Lower bioavailability does not necessarily mean lower effectiveness -- it means that dosing is adjusted accordingly. Sublingual and oral forms are the basis of at-home ketamine therapy, which has made treatment accessible and affordable for far more patients.
How Long Do the Effects Last?
The duration of ketamine's antidepressant effects varies by individual and treatment protocol:
- Single infusion: Effects typically last 3-14 days before gradually fading
- Initial series (6 IV infusions): Cumulative benefit may last several weeks to months
- Ongoing oral/sublingual therapy: Regular dosing (daily or several times per week) maintains steady benefit as long as treatment continues
This is why most treatment protocols involve ongoing maintenance rather than a one-time intervention. At-home providers like Kalm Health are designed around this sustained treatment model, with monthly plans starting at $124/month and no dose cap to limit your clinician's ability to optimize your treatment.
Ketamine vs Esketamine (Spravato)
Ketamine is a racemic mixture of two mirror-image molecules: S-ketamine (esketamine) and R-ketamine. The FDA-approved Spravato contains only the S-enantiomer.
- Racemic ketamine has a longer research track record and some evidence suggests R-ketamine may contribute meaningfully to the antidepressant effect with fewer dissociative side effects
- Esketamine (Spravato) has the advantage of FDA approval, which can facilitate insurance coverage, but must be given in certified clinics
- Many clinicians and researchers consider racemic ketamine to be at least as effective as esketamine for depression, and it is significantly more affordable in oral/sublingual form
Explore Affordable Ketamine Treatment
Kalm Health offers at-home ketamine therapy starting at $124/month with no dose cap and a free initial consultation.
Visit Kalm Health